CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Vaxart, Inc. - VXRT CFD

    0.67
    3.03%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.06
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Vaxart Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 0.66
    Open* 0.67
    1-Year Change* -36.19%
    Day's Range* 0.66 - 0.68
    52 wk Range 0.56-1.59
    Average Volume (10 days) 795.59K
    Average Volume (3 months) 15.61M
    Market Cap 116.66M
    P/E Ratio -100.00K
    Shares Outstanding 152.04M
    Revenue 4.16M
    EPS -0.64
    Dividend (Yield %) N/A
    Beta 0.73
    Next Earnings Date Mar 13, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 0.68 0.02 3.03% 0.66 0.68 0.66
    Dec 7, 2023 0.66 -0.01 -1.49% 0.67 0.68 0.66
    Dec 6, 2023 0.66 -0.03 -4.35% 0.69 0.69 0.66
    Dec 5, 2023 0.68 -0.01 -1.45% 0.69 0.70 0.66
    Dec 4, 2023 0.70 0.00 0.00% 0.70 0.70 0.69
    Dec 1, 2023 0.70 0.01 1.45% 0.69 0.70 0.67
    Nov 30, 2023 0.69 0.01 1.47% 0.68 0.72 0.68
    Nov 29, 2023 0.67 -0.01 -1.47% 0.68 0.70 0.67
    Nov 28, 2023 0.69 0.00 0.00% 0.69 0.70 0.67
    Nov 27, 2023 0.70 0.02 2.94% 0.68 0.71 0.67
    Nov 24, 2023 0.69 0.01 1.47% 0.68 0.70 0.67
    Nov 22, 2023 0.69 -0.04 -5.48% 0.73 0.74 0.69
    Nov 21, 2023 0.73 -0.02 -2.67% 0.75 0.75 0.72
    Nov 20, 2023 0.75 0.00 0.00% 0.75 0.82 0.75
    Nov 17, 2023 0.77 0.00 0.00% 0.77 0.78 0.76
    Nov 16, 2023 0.77 -0.05 -6.10% 0.82 0.83 0.74
    Nov 15, 2023 0.81 0.08 10.96% 0.73 0.85 0.73
    Nov 14, 2023 0.74 0.06 8.82% 0.68 0.74 0.68
    Nov 13, 2023 0.69 -0.03 -4.17% 0.72 0.72 0.66
    Nov 10, 2023 0.72 0.03 4.35% 0.69 0.72 0.67

    Vaxart, Inc. Events

    Time (UTC) Country Event
    Wednesday, March 13, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 Vaxart Inc Earnings Release
    Q4 2023 Vaxart Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0.107 0.892 4.046 9.862 4.159
    Revenue 0.107 0.892 4.046 9.862 4.159
    Total Operating Expense 107.734 69.855 34.216 25.747 19.155
    Selling/General/Admin. Expenses, Total 29.386 21.89 15.202 6.187 6.681
    Research & Development 81.054 48.749 19.863 14.54 17.275
    Depreciation / Amortization
    Interest Expense (Income) - Net Operating
    Operating Income -107.627 -68.963 -30.17 -15.885 -14.996
    Interest Income (Expense), Net Non-Operating 1.241 0.08 0.062 -0.198 -1.032
    Other, Net -1.305 -1.48 -1.874 -2.073 -1.859
    Net Income Before Taxes -107.691 -70.363 -31.982 -18.155 -17.898
    Net Income After Taxes -107.758 -70.47 -32.22 -18.645 -18.007
    Net Income Before Extra. Items -107.758 -70.47 -32.22 -18.645 -18.007
    Net Income -107.758 -70.47 -32.22 -18.645 -18.007
    Income Available to Common Excl. Extra. Items -107.758 -70.47 -32.22 -18.645 -18.346
    Income Available to Common Incl. Extra. Items -107.758 -70.47 -32.22 -18.645 -18.346
    Diluted Net Income -107.758 -70.47 -32.22 -18.645 -18.346
    Diluted Weighted Average Shares 127.684 121.454 88.2958 21.5695 6.31607
    Diluted EPS Excluding Extraordinary Items -0.84394 -0.58022 -0.36491 -0.86441 -2.90466
    Dividends per Share - Common Stock Primary Issue
    Diluted Normalized EPS -0.85772 -0.58442 -0.37116 -0.71317 -3.39761
    Gain (Loss) on Sale of Assets 0 0.001 -0.011
    Total Extraordinary Items
    Total Adjustments to Net Income 0 0 -0.339
    Unusual Expense (Income) -2.706 -0.784 -0.849 5.02 -4.801
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 1.358 0.675 0.022 0 0
    Revenue 1.358 0.675 0.022 0 0
    Total Operating Expense 24.411 26.247 24.2 29.426 29.247
    Selling/General/Admin. Expenses, Total 5.598 6.625 6.447 6.96 9.321
    Research & Development 18.813 19.622 20.459 22.466 19.926
    Unusual Expense (Income) -2.706
    Operating Income -23.053 -25.572 -24.178 -29.426 -29.247
    Interest Income (Expense), Net Non-Operating 0.71 0.639 0.593 0.458 0.155
    Other, Net -0.188 -0.178 -0.317 -0.325 -0.323
    Net Income Before Taxes -22.531 -25.111 -23.902 -29.293 -29.415
    Net Income After Taxes -22.55 -25.14 -23.918 -29.309 -29.43
    Net Income Before Extra. Items -22.55 -25.14 -23.918 -29.309 -29.43
    Net Income -22.55 -25.14 -23.918 -29.309 -29.43
    Income Available to Common Excl. Extra. Items -22.55 -25.14 -23.918 -29.309 -29.43
    Income Available to Common Incl. Extra. Items -22.55 -25.14 -23.918 -29.309 -29.43
    Diluted Net Income -22.55 -25.14 -23.918 -29.309 -29.43
    Diluted Weighted Average Shares 139.594 135.213 131.612 126.89 126.428
    Diluted EPS Excluding Extraordinary Items -0.16154 -0.18593 -0.18173 -0.23098 -0.23278
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.16154 -0.18593 -0.1951 -0.23098 -0.23278
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 99.451 169.167 128.531 17.598 14.645
    Cash and Short Term Investments 95.717 166.487 126.87 13.526 11.506
    Cash & Equivalents 30.834 70.978 60.005 13.526 11.506
    Short Term Investments 49.704 22.742 0
    Total Receivables, Net 0.02 0.071 0.334 3.619 1.796
    Accounts Receivable - Trade, Net 0 3.619 0
    Prepaid Expenses 3.714 2.609 1.327 0.453 1.343
    Total Assets 153.847 221.168 152.582 37.032 35.227
    Property/Plant/Equipment, Total - Net 41.3 19.769 8.318 2.2 1.066
    Property/Plant/Equipment, Total - Gross 44.572 21.074 8.891 2.636
    Accumulated Depreciation, Total -3.272 -1.305 -0.573 -1.57
    Total Current Liabilities 17.921 10.783 11.763 9.174 7.475
    Accounts Payable 5.514 3.872 2.133 0.852 0.962
    Accrued Expenses 8.444 5.339 6.219 5.406 1.407
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0.095 0.836 2.779 2.916 1.667
    Other Current Liabilities, Total 3.868 0.736 0.632 3.439
    Total Liabilities 43.25 33.637 29.178 24.08 23.989
    Total Long Term Debt 5.621 10.686 12.15 13.416 1.944
    Long Term Debt 5.621 10.686 12.15 13.416 1.944
    Other Liabilities, Total 19.708 12.168 5.265 1.49 14.57
    Total Equity 110.597 187.531 123.404 12.952 11.238
    Common Stock 0.013 0.013 0.011 4.825 0.714
    Additional Paid-In Capital 437.992 406.943 272.274 124.788 108.513
    Retained Earnings (Accumulated Deficit) -327.109 -219.351 -148.881 -116.661 -97.989
    Other Equity, Total -0.299 -0.074
    Total Liabilities & Shareholders’ Equity 153.847 221.168 152.582 37.032 35.227
    Total Common Shares Outstanding 134.199 125.594 110.271 48.255 7.14119
    Intangibles, Net 5.02 10.624 15.361 17.093 19.413
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Other Long Term Assets, Total 3.568 0.89 0.372 0.141 0.103
    Cash 15.179 72.767 66.865
    Goodwill, Net 4.508 4.508
    Long Term Investments 0 16.21
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 57.1 71.261 75.83 99.451 120.38
    Cash and Short Term Investments 53.037 67.905 71.811 95.717 114.767
    Cash 5.263 5.245 10.255 15.179 19.895
    Cash & Equivalents 27.975 38.032 38.179 30.834 30.873
    Short Term Investments 19.799 24.628 23.377 49.704 63.999
    Total Receivables, Net 0.424 0.029 0.264 0.02 0
    Accounts Receivable - Trade, Net 0.424 0.029 0.264 0
    Prepaid Expenses 3.639 3.327 3.755 3.714 5.613
    Total Assets 105.642 122.653 129.851 153.847 175.309
    Property/Plant/Equipment, Total - Net 38.679 40.722 42.216 41.3 38.887
    Property/Plant/Equipment, Total - Gross 44.621 45.832 46.382 44.572 41.498
    Accumulated Depreciation, Total -5.942 -5.11 -4.166 -3.272 -2.611
    Intangibles, Net 4.472 4.654 4.837 5.02 9.611
    Long Term Investments 0 0
    Other Long Term Assets, Total 0.883 1.508 2.46 3.568 1.923
    Total Current Liabilities 11.268 13.883 15.683 17.921 21.74
    Accounts Payable 1.339 4.199 3.882 5.514 7.916
    Accrued Expenses 7.931 7.409 7.23 8.444 9.876
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0.656 1.346 3.694 3.868 2.617
    Total Liabilities 34.121 37.58 40.098 43.25 53.002
    Total Long Term Debt 4.633 4.869 4.997 5.621 11.027
    Other Liabilities, Total 18.22 18.828 19.418 19.708 20.235
    Total Equity 71.521 85.073 89.753 110.597 122.307
    Common Stock 0.015 0.015 0.014 0.013 0.013
    Additional Paid-In Capital 463.755 459.912 442.068 437.992 426.003
    Retained Earnings (Accumulated Deficit) -392.199 -374.799 -352.249 -327.109 -303.191
    Other Equity, Total -0.011 -0.024 -0.07 -0.299 -0.518
    Total Liabilities & Shareholders’ Equity 105.642 122.653 129.851 153.847 175.309
    Total Common Shares Outstanding 152.037 151.983 135.597 134.199 128.331
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Goodwill, Net 4.508 4.508 4.508 4.508 4.508
    Current Port. of LT Debt/Capital Leases 1.342 0.929 0.877 0.095 1.331
    Long Term Debt 4.633 4.869 4.997 5.621 11.027
    Treasury Stock - Common -0.039 -0.031 -0.01
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -107.758 -70.47 -32.22 -18.645 -18.007
    Cash From Operating Activities -94.779 -59.832 -23.75 -13.09 -14.548
    Cash From Operating Activities 5.805 4.208 2.71 3.596 3.203
    Non-Cash Items 13.872 8.55 2.955 0.677 -2.194
    Changes in Working Capital -6.698 -2.12 2.805 1.282 2.45
    Cash From Investing Activities -20.415 -49.097 -1.22 -0.85 26.212
    Capital Expenditures -9.601 -5.157 -1.223 -0.85 -0.707
    Other Investing Cash Flow Items, Total -10.814 -43.94 0.003 0 26.919
    Cash From Financing Activities 17.462 125.804 138.314 15.96 -1.729
    Financing Cash Flow Items 0 0.652
    Issuance (Retirement) of Debt, Net 0 0 -3.799 -1.742
    Net Change in Cash -97.732 16.875 113.344 2.02 9.935
    Cash Interest Paid 0 0 0 0.227 0.356
    Issuance (Retirement) of Stock, Net 17.462 125.804 137.662 19.759 0.013
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -25.14 -107.758 -83.84 -54.531 -25.101
    Cash From Operating Activities -24.46 -94.779 -65.627 -51.012 -25.113
    Cash From Operating Activities 2.062 5.805 3.915 2.352 1.131
    Non-Cash Items 2.264 13.872 11.017 7.132 3.435
    Changes in Working Capital -3.646 -6.698 3.281 -5.965 -4.578
    Cash From Investing Activities 25.461 -20.415 -36.216 -5.143 3.732
    Capital Expenditures -1.239 -9.601 -10.738 -3.672 -1.346
    Other Investing Cash Flow Items, Total 26.7 -10.814 -25.478 -1.471 5.078
    Cash From Financing Activities 1.42 17.462 8.866 3.878 1.04
    Issuance (Retirement) of Stock, Net 1.43 17.462 8.866 3.878 1.04
    Net Change in Cash 2.421 -97.732 -92.977 -52.277 -20.341
    Financing Cash Flow Items -0.01
    Cash Interest Paid 0
    Issuance (Retirement) of Debt, Net
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Cantor Fitzgerald, L.P Investment Advisor 4.663 7086341 7086341 2023-06-30 MED
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.5367 6894401 -169485 2023-06-30 LOW
    Millennium Management LLC Hedge Fund 1.4106 2143638 2067766 2023-06-30 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.2459 1893422 -5968529 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.0324 1568909 -1093564 2023-06-30 LOW
    Renaissance Technologies LLC Hedge Fund 0.5212 792005 735548 2023-06-30 HIGH
    Citadel Advisors LLC Hedge Fund 0.4933 749684 270134 2023-06-30 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 0.4867 739643 -253580 2023-06-30 LOW
    Finney Michael J Individual Investor 0.4414 670840 7375 2023-06-26 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3466 526745 -2126874 2023-06-30 LOW
    Rokos Capital Management LLP Hedge Fund 0.329 500000 500000 2023-06-30 HIGH
    Two Sigma Investments, LP Hedge Fund 0.2985 453670 -1839853 2023-06-30 HIGH
    Morgan Stanley & Co. LLC Research Firm 0.286 434690 -21186 2023-06-30 MED
    Susquehanna International Group, LLP Investment Advisor 0.2608 396311 324032 2023-06-30 MED
    Cubist Systematic Strategies, LLC Hedge Fund 0.2314 351661 341109 2023-06-30 HIGH
    Goldman Sachs & Company, Inc. Research Firm 0.2259 343288 254141 2023-06-30 MED
    XTX Markets LLC Venture Capital 0.2197 333829 333829 2023-06-30 HIGH
    D. E. Shaw & Co., L.P. Hedge Fund 0.1708 259516 -721867 2023-06-30 MED
    IHT Wealth Management, LLC Investment Advisor 0.1692 257128 -4095 2023-06-30 LOW
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.156 237116 -773984 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Vaxart Company profile

    Vaxart Inc. is a clinical-stage biotechnology company headquartered in San Francisco, California. It works on the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. It also has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company’s proprietary oral vaccine platform for the Janssen universal influenza vaccine program.

    Vaxart is traded on the Nasdaq under the ticker VXRT. In its finance for Q4 2021, the company reported revenue totalling $0.89m, a 77.9% decrease from the $4.04m result in 2020.

    Industry: Bio Therapeutic Drugs

    170 Harbor Way, Suite 300
    SOUTH SAN FRANCISCO
    CALIFORNIA 94080
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    XRP/USD

    0.63 Price
    -6.600% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Gold

    1,996.96 Price
    -0.400% 1D Chg, %
    Long position overnight fee -0.0199%
    Short position overnight fee 0.0117%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    BTC/USD

    42,218.15 Price
    -4.110% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    US100

    16,039.80 Price
    -0.230% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading